Five Things Must Know for Odactra Sublingual Tablet (Allergen Extract 12 SQ-HDM)!

Odactra is changing how we treat dust mite allergy—it’s the first and only FDA-approved sublingual immunotherapy tablet for house dust mite–induced allergic rhinitis, with or without conjunctivitis, in patients 5 through 65 years of age. For people dealing with year-round sneezing, congestion, itchy eyes and nose, and runny nose, this once-daily tablet goes beyond symptom relief by retraining the immune system itself.

In this video, Dr. Lin, a board-certified allergist and immunologist, walks you through the five key things to know about Odactra: who it’s approved for, how it works, how to take it safely, important warnings and precautions, and what the clinical studies tell us about side effects and safety in both adults and children.

💡 Curious if Odactra might be right for you or your child? Want to know what to expect in the first weeks of treatment and why carrying epinephrine is essential? This episode covers it all with clear, evidence-based guidance.

📌 Watch Now & Learn the Truth About Odactra!

📢 Subscribe for more science-based medical insights, and turn on notifications so you never miss an update!

💬 Do you or someone you know struggle with dust mite allergy? Share your thoughts or experiences in the comments—we’d love to hear from you!

🔗 Related Videos & Resources:
💡 Three Secrets Need to Know about Odactra Sublingual Tablet (Allergen Extract 12 SQ-HDM)!
👉 Coming up.

#Odactra #DustMiteAllergy #Dustmites #AllergicRhinitis #Conjunctivitis #SublingualImmunotherapy #SLIT #AllergyTreatment #FDAApproved #Medician #DoctorExplains #AllergyAndImmunology #MedicianChannel #MedicalBreakthrough #PediatricAllergy #PatientEducation #MedicianAllergy